We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
JetBlue
JBLU
$1.62B
| $443K | ﹤0.01% |
50,030
+24,276
| +94% | +$176K |
|
1402
Federated Hermes
FHI
$4.23B
| $439K | ﹤0.01% |
12,243
| – | – |
|
1403
Brilliant Earth
BRLT
$23.3M
| $435K | ﹤0.01% |
112,080
+41,375
| +59% | +$157K |
|
1404
Calix
CALX
$2.23B
| $435K | ﹤0.01% |
8,708
-81
| -0.9% | -$3.9K |
|
1405
Regions Financial
RF
$24.3B
| $434K | ﹤0.01% |
24,335
-11,973
| -33% | -$211K |
|
1406
Independence Realty Trust
IRT
$3.52B
| $430K | ﹤0.01% |
23,618
-11,769
| -33% | -$201K |
|
1407
Nektar Therapeutics
NKTR
$2.3B
| $430K | ﹤0.01% |
49,818
-76,901
| -61% | -$820K |
|
1408
Southwest Gas
SWX
$6.28B
| $430K | ﹤0.01% |
6,750
-2,602
| -28% | -$154K |
|
1409
Crane Co
CR
$11.4B
| $427K | ﹤0.01% |
+4,786
| New | +$369K |
|
|
GOLD
1410
Gold.com Inc
GOLD
$1.37B
| $424K | ﹤0.01% |
+11,335
| New | +$411K |
|
1411
Old Second Bancorp
OSBC
$1.27B
| $424K | ﹤0.01% |
32,451
-2,347
| -7% | -$29.9K |
|
1412
Otis Worldwide
OTIS
$26.4B
| $422K | ﹤0.01% |
4,746
-2,456
| -34% | -$207K |
|
1413
RPC Inc
RES
$1.33B
| $421K | ﹤0.01% |
58,913
+50,193
| +576% | +$368K |
|
1414
Praxis Precision Medicines
PRAX
$8.63B
| $421K | ﹤0.01% |
24,379
-1,472
| -6% | -$22.5K |
|
1415
Park Hotels & Resorts
PK
$3B
| $419K | ﹤0.01% |
32,707
-2,311
| -7% | -$29.5K |
|
1416
Equity Bancshares
EQBK
$1.01B
| $419K | ﹤0.01% |
18,400
| – | – |
|
|
SKYT
1417
DELISTED
SkyWater Technology
SKYT
| $410K | ﹤0.01% |
43,557
+26,887
| +161% | +$258K |
|
1418
Gold Fields
GFI
$37.4B
| $408K | ﹤0.01% |
29,531
-72
| -0.2% | -$1.09K |
|
1419
Lumen
LUMN
$6.88B
| $406K | ﹤0.01% |
179,669
+116,558
| +185% | +$257K |
|
|
DISH
1420
DELISTED
DISH Network Corp.
DISH
| $403K | ﹤0.01% |
61,186
-10,368
| -14% | -$73.4K |
|
1421
DXP Enterprises
DXPE
$2.85B
| $403K | ﹤0.01% |
11,064
-1,471
| -12% | -$44.4K |
|
|
SFIX
1422
Stitch Fix
SFIX
$388M
| $401K | ﹤0.01% |
104,029
-200,812
| -66% | -$761K |
|
1423
Sunrun
RUN
$1.99B
| $400K | ﹤0.01% |
22,421
-543
| -2% | -$10.1K |
|
1424
Expensify
EXFY
$210M
| $399K | ﹤0.01% |
50,000
+10,000
| +25% | +$73.4K |
|
1425
First Financial Corp
THFF
$914M
| $399K | ﹤0.01% |
12,279
-508
| -4% | -$17.3K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.